Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-026183

Chief Financial Officer sold 20,000 shares at an average $41.30 ($826,005)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-04-06 Option exercise +10,000 $6.32 $63,200 31,604 D
Cohen Chad M Chief Financial Officer 2021-04-06 Sale −10,000 $40.95 $409,500 21,604 D
Cohen Chad M Chief Financial Officer 2021-04-07 Option exercise +10,000 $6.32 $63,200 31,604 D
Cohen Chad M Chief Financial Officer 2021-04-07 Sale −9,194 $41.59 $382,378 22,410 D
Cohen Chad M Chief Financial Officer 2021-04-07 Sale −806 $42.34 $34,126 21,604 D
Derivatives
Cohen Chad M Chief Financial Officer 2021-04-06 Option exercise · Stock Option (Right to Buy) −10,000 35,000 D
Cohen Chad M Chief Financial Officer 2021-04-07 Option exercise · Stock Option (Right to Buy) −10,000 25,000 D
Open-market sales · 20,000 sh · avg $41.30 · $826,005
Loading xslF345X03/doc4.xml…